Voyager Therapeutics, Inc. OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax
Voyager Therapeutics, Inc. (VYGR) reported OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax of -$53.00 thousand for the 3-month period ending 2017-09-30, per its 10-Q filed 2018-11-07.
Discontinued › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax · last filed 2019-02-26
- Voyager Therapeutics, Inc. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for the quarter ending 2017-09-30 was -$53.00K, a 109.30% decline year-over-year.
- Voyager Therapeutics, Inc. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for the quarter ending 2017-06-30 was -$191.00K.
- Voyager Therapeutics, Inc. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for the quarter ending 2017-03-31 was $244.00K.
- Voyager Therapeutics, Inc. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for the quarter ending 2016-12-31 was -$442.00K.
- Voyager Therapeutics, Inc. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for fiscal 2016 was $128.00K.
| Period end | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax 3 month | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax 6 month | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax 9 month | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax 12 month |
|---|---|---|---|---|
| 2017-09-30 | -$53.00K 10-Q · filed 2018-11-07 | -$244.00K derived: sum of 2 quarters · filed 2018-11-07 | $0.00 10-Q · filed 2017-11-02 | -$442.00K derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | -$191.00K 10-Q · filed 2018-08-07 | $53.00K 10-Q · filed 2018-08-07 | -$389.00K derived: sum of 3 quarters · filed 2019-02-26 | $181.00K derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | $244.00K 10-Q · filed 2018-05-10 | -$198.00K derived: sum of 2 quarters · filed 2019-02-26 | $372.00K derived: sum of 3 quarters · filed 2019-02-26 | |
| 2016-12-31 | -$442.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $128.00K derived: sum of 2 quarters · filed 2019-02-26 | $128.00K 10-K · filed 2019-02-26 | |
| 2016-09-30 | $570.00K 10-Q · filed 2017-11-02 | $570.00K 10-Q · filed 2017-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |